The NIH is launching a Second Stage of NIH Common Fund program: Extracellular RNA Communication. We are reaching out to those with possible interest in the series of funding opportunities that we have recently released. If you would be willing to distribute information about these opportunities to your community, we would appreciate it.
The First Stage of the Common Fund’s Extracellular RNA Communication program aimed to establish fundamental biological principles of extracellular RNA secretion, delivery, and impact on recipient cells; to describe exRNAs in human biofluids and the extent to which non-human exRNAs are present; to test clinical utility of exRNAs; and to provide a data and a resource repository for the community at-large. Since founding of the program awardees generated over 428 peer-reviewed publications, including 37 publications describing refinement of protocols. At present they have generated 135 datasets, 52 software packages and 23 protocols all of which have been made available through the exRNA Portal
The three opportunities for this program are now available:
- RM18-026: Limited Competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed)
- RM18-027: Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed)
- RM18-028: Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)
For those who are interested, letters of intent are due September 10, 2018 and applications are due October 23, 2018. An informational webinar will be held on August 24, 2018 from 2-3:30 PM, EST.
Join us via WebEx using this link:
Call-in toll number (US/Canada): 1-650-479-3208
Event number: 629 822 206
Event password: exRNA
For additional information, please visit https://commonfund.nih.gov/exrna